首页 > 最新文献

Asian Journal of Urology最新文献

英文 中文
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades 诊断上尿路上皮癌:回顾诊断输尿管镜的作用和近二十年来的新进展
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-04-01 DOI: 10.1016/j.ajur.2022.08.003
Paul Gravestock , Daniel Cullum , Bhaskar Somani , Rajan Veeratterapillay

Objective

The role of ureteroscopy in the diagnosis of upper tract urothelial carcinoma is yet to be fully determined. We aimed to provide an up to date evaluation of its role and the emerging technologies in the field.

Methods

A literature search of the last two decades (from 24th May, 2001 to 24th May, 2021) was carried out identifying 147 papers for potential inclusion within this narrative review.

Results

Diagnostic ureteroscopy is undeniably useful in its ability to visualise and biopsy indeterminate lesions, and to risk stratify malignant lesions that may be suitable for kidney sparing surgery. However, an increased risk of intravesical recurrence following nephroureterectomy when a prior diagnostic ureteroscopy has been performed, inadequate sampling at biopsy, complications from the procedure, and difficult ureteric access are all potential drawbacks. Furthermore, whilst generally an accurate diagnostic procedure, it risks missing carcinoma in-situ lesions. Despite this, evidence shows that routine use of ureteroscopy changes the management of patients in a large proportion of cases, preventing unnecessary surgery or facilitating kidney sparing surgery. The overall rate of complications is low, and improved biopsy techniques and the use of tissue biomarkers for improved staging and grading are encouraging. The risks of delays to definitive management and post-ureteroscopy intravesical recurrence do not seem to affect survival, and trials are in progress to determine whether intravesical therapy can mitigate the latter. Further promising techniques are being investigated to improve shortcomings, particularly in relation to improved diagnosis of carcinoma in situ and preoperative staging.

Conclusion

Ureteroscopy has a role in the diagnosis of upper tract malignancy, though whether it should be used routinely is yet to be determined.

目的输尿管镜在诊断上尿路上皮癌中的作用尚未完全确定。我们的目的是对输尿管镜的作用和该领域的新兴技术进行最新评估。方法我们对过去二十年(2001 年 5 月 24 日至 2021 年 5 月 24 日)的文献进行了检索,确定了 147 篇可能纳入本叙事性综述的论文。结果输尿管镜诊断在观察和活检不确定病变以及对适合进行保肾手术的恶性病变进行风险分层方面的作用毋庸置疑。然而,如果事先进行了诊断性输尿管镜检查,则肾切除术后膀胱内复发的风险会增加,活检取样不足、手术并发症和输尿管入路困难都是潜在的缺点。此外,虽然活检通常是一种准确的诊断方法,但也存在漏诊原位癌病变的风险。尽管如此,有证据表明,输尿管镜检查的常规使用在很大程度上改变了患者的治疗方案,避免了不必要的手术,或有利于进行保肾手术。总的并发症发生率很低,活检技术的改进和组织生物标记物在分期和分级方面的应用也令人鼓舞。延迟明确治疗和输尿管镜检查后膀胱内复发的风险似乎并不影响患者的生存,目前正在进行试验,以确定膀胱内治疗能否减轻后者的风险。输尿管镜检查在上尿路恶性肿瘤的诊断中具有一定的作用,但是否应该常规使用还有待确定。
{"title":"Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades","authors":"Paul Gravestock ,&nbsp;Daniel Cullum ,&nbsp;Bhaskar Somani ,&nbsp;Rajan Veeratterapillay","doi":"10.1016/j.ajur.2022.08.003","DOIUrl":"10.1016/j.ajur.2022.08.003","url":null,"abstract":"<div><h3>Objective</h3><p>The role of ureteroscopy in the diagnosis of upper tract urothelial carcinoma is yet to be fully determined. We aimed to provide an up to date evaluation of its role and the emerging technologies in the field.</p></div><div><h3>Methods</h3><p>A literature search of the last two decades (from 24th May, 2001 to 24th May, 2021) was carried out identifying 147 papers for potential inclusion within this narrative review.</p></div><div><h3>Results</h3><p>Diagnostic ureteroscopy is undeniably useful in its ability to visualise and biopsy indeterminate lesions, and to risk stratify malignant lesions that may be suitable for kidney sparing surgery. However, an increased risk of intravesical recurrence following nephroureterectomy when a prior diagnostic ureteroscopy has been performed, inadequate sampling at biopsy, complications from the procedure, and difficult ureteric access are all potential drawbacks. Furthermore, whilst generally an accurate diagnostic procedure, it risks missing carcinoma <em>in-situ</em> lesions. Despite this, evidence shows that routine use of ureteroscopy changes the management of patients in a large proportion of cases, preventing unnecessary surgery or facilitating kidney sparing surgery. The overall rate of complications is low, and improved biopsy techniques and the use of tissue biomarkers for improved staging and grading are encouraging. The risks of delays to definitive management and post-ureteroscopy intravesical recurrence do not seem to affect survival, and trials are in progress to determine whether intravesical therapy can mitigate the latter. Further promising techniques are being investigated to improve shortcomings, particularly in relation to improved diagnosis of carcinoma <em>in situ</em> and preoperative staging.</p></div><div><h3>Conclusion</h3><p>Ureteroscopy has a role in the diagnosis of upper tract malignancy, though whether it should be used routinely is yet to be determined.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 242-252"},"PeriodicalIF":2.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388222001059/pdfft?md5=3e98f1903159b1b3b2b8386e1bea7c47&pid=1-s2.0-S2214388222001059-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42609403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical management of urolithiasis: Great efforts and limited progress 泌尿系结石的医学治疗:巨大的努力和有限的进展
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-04-01 DOI: 10.1016/j.ajur.2023.05.001
Victoria Jahrreiss , Christian Seitz , Fahad Quhal

Objective

To provide a comprehensive review on the existing literature on medical management of urolithiasis.

Methods

A thorough literature review was performed using Medline, PubMed/PMC, Embase, and the Cochrane Database of Systematic Reviews up to December 2022 to identify publications on the medical management of urolithiasis. Studies that assessed dietary and pharmacologic management of urolithiasis were reviewed; studies on medical expulsive therapy were not included in this review.

Results

Medical management of urolithiasis ranges from the prophylactic management of kidney stone disease to dissolution therapies. While most treatment concepts have been long established, large randomized controlled trials are scarce. Dietary modification and increased fluid intake remain cornerstones in the conservative management of urolithiasis. A major limitation for medical management of urolithiasis is poor patient compliance.

Conclusion

Medical management of urolithiasis is more important in patients with recurrent urolithiasis and patients with metabolic abnormalities putting them at higher risk of developing stones. Although medical management can be effective in limiting stone recurrence, medical interventions often fail due to poor compliance.

方法 使用 Medline、PubMed/PMC、Embase 和 Cochrane 系统综述数据库对截至 2022 年 12 月的文献进行了全面综述,以确定有关尿路结石医学治疗的出版物。结果尿路结石的医学治疗包括从肾结石疾病的预防性治疗到溶解疗法。虽然大多数治疗理念早已确立,但大型随机对照试验却很少。饮食调节和增加液体摄入量仍然是尿路结石保守治疗的基石。结论尿路结石的药物治疗对于反复发作的尿路结石患者和新陈代谢异常、患结石风险较高的患者更为重要。虽然药物治疗可以有效限制结石复发,但由于患者依从性差,药物干预往往会失败。
{"title":"Medical management of urolithiasis: Great efforts and limited progress","authors":"Victoria Jahrreiss ,&nbsp;Christian Seitz ,&nbsp;Fahad Quhal","doi":"10.1016/j.ajur.2023.05.001","DOIUrl":"10.1016/j.ajur.2023.05.001","url":null,"abstract":"<div><h3>Objective</h3><p>To provide a comprehensive review on the existing literature on medical management of urolithiasis.</p></div><div><h3>Methods</h3><p>A thorough literature review was performed using Medline, PubMed/PMC, Embase, and the Cochrane Database of Systematic Reviews up to December 2022 to identify publications on the medical management of urolithiasis. Studies that assessed dietary and pharmacologic management of urolithiasis were reviewed; studies on medical expulsive therapy were not included in this review.</p></div><div><h3>Results</h3><p>Medical management of urolithiasis ranges from the prophylactic management of kidney stone disease to dissolution therapies. While most treatment concepts have been long established, large randomized controlled trials are scarce. Dietary modification and increased fluid intake remain cornerstones in the conservative management of urolithiasis. A major limitation for medical management of urolithiasis is poor patient compliance.</p></div><div><h3>Conclusion</h3><p>Medical management of urolithiasis is more important in patients with recurrent urolithiasis and patients with metabolic abnormalities putting them at higher risk of developing stones. Although medical management can be effective in limiting stone recurrence, medical interventions often fail due to poor compliance.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 149-155"},"PeriodicalIF":2.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221438822300067X/pdfft?md5=55e75fb4478117c9cc6fd5d05a4adcc8&pid=1-s2.0-S221438822300067X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47596222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor necrosis factor-alpha, transforming growth factor-beta, degree of lower urinary tract symptoms as predictors of erectile dysfunction in benign prostatic hyperplasia patients 肿瘤坏死因子- α、转化生长因子- β、下尿路症状程度作为良性前列腺增生患者勃起功能障碍的预测因子
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-04-01 DOI: 10.1016/j.ajur.2023.07.003
Gede W.K. Duarsa , Yeremia G. Kusumah , Ronald Sugianto , Pande M.W. Tirtayasa , Tjokorda G.B. Mahadewa

Objective

Erectile dysfunction (ED) is a condition of insufficient penile erection, consistently or recurrently, for sexual activity. Tumor necrosis factor-alpha (TNF-α) induces transforming growth factor-beta (TGF-β), which causes the transition of epithelial cells into mesenchymal cells that affect ED. This study aimed to evaluate the roles of TNF-α, TGF-β, degree of lower urinary tract symptoms, and prostatic volume for the presence of ED in benign prostatic hyperplasia (BPH) patients.

Methods

Our study performed an analytic observational retrospective cohort study using secondary data from four hospitals in Bali, Indonesia, including medical records and other administrative data. The sample was BPH patients with several history qualifications.

Results

Our sample was 83 respondents, ranging from 50 years to 80 years, 61 respondents with ED and 22 with non-ED. The International Prostate Symptom Score showed a significant result, which indicates that ED is more common in patients with higher International Prostate Symptom Score (p=0.002). Moreover, the TNF-α of ≥43.9 pg/mg and TGF-β of ≥175.8 pg/mL were significantly associated with the presence of ED in BPH patients (p<0.0001). Despite these results, prostate volume is not significant with ED (p=0.947).

Conclusion

TNF-α, TGF-β, and lower urinary tract symptoms severity can predict the occurrence of ED in BPH, while prostatic volume was not significant.

目的勃起功能障碍(ED)是指阴茎持续或反复勃起不足,无法进行性活动。肿瘤坏死因子-α(TNF-α)可诱导转化生长因子-β(TGF-β),使上皮细胞转化为间质细胞,从而影响 ED。本研究旨在评估 TNF-α、TGF-β、下尿路症状程度和前列腺体积对良性前列腺增生症(BPH)患者出现 ED 的作用。样本为具有多种病史资格的良性前列腺增生症患者。结果我们的样本有 83 名受访者,年龄从 50 岁到 80 岁不等,其中 61 名受访者患有前列腺增生症,22 名受访者没有前列腺增生症。国际前列腺症状评分结果显示,ED在国际前列腺症状评分较高的患者中更为常见(P=0.002)。此外,TNF-α≥43.9 pg/mg和TGF-β≥175.8 pg/mL与良性前列腺增生症患者出现ED显著相关(p<0.0001)。结论TNF-α、TGF-β和下尿路症状严重程度可预测良性前列腺增生症患者发生 ED 的情况,而前列腺体积与 ED 的关系不大。
{"title":"Tumor necrosis factor-alpha, transforming growth factor-beta, degree of lower urinary tract symptoms as predictors of erectile dysfunction in benign prostatic hyperplasia patients","authors":"Gede W.K. Duarsa ,&nbsp;Yeremia G. Kusumah ,&nbsp;Ronald Sugianto ,&nbsp;Pande M.W. Tirtayasa ,&nbsp;Tjokorda G.B. Mahadewa","doi":"10.1016/j.ajur.2023.07.003","DOIUrl":"10.1016/j.ajur.2023.07.003","url":null,"abstract":"<div><h3>Objective</h3><p>Erectile dysfunction (ED) is a condition of insufficient penile erection, consistently or recurrently, for sexual activity. Tumor necrosis factor-alpha (TNF-α) induces transforming growth factor-beta (TGF-β), which causes the transition of epithelial cells into mesenchymal cells that affect ED. This study aimed to evaluate the roles of TNF-α, TGF-β, degree of lower urinary tract symptoms, and prostatic volume for the presence of ED in benign prostatic hyperplasia (BPH) patients.</p></div><div><h3>Methods</h3><p>Our study performed an analytic observational retrospective cohort study using secondary data from four hospitals in Bali, Indonesia, including medical records and other administrative data. The sample was BPH patients with several history qualifications.</p></div><div><h3>Results</h3><p>Our sample was 83 respondents, ranging from 50 years to 80 years, 61 respondents with ED and 22 with non-ED. The International Prostate Symptom Score showed a significant result, which indicates that ED is more common in patients with higher International Prostate Symptom Score (<em>p</em>=0.002). Moreover, the TNF-α of ≥43.9 pg/mg and TGF-β of ≥175.8 pg/mL were significantly associated with the presence of ED in BPH patients (<em>p</em>&lt;0.0001). Despite these results, prostate volume is not significant with ED (<em>p</em>=0.947).</p></div><div><h3>Conclusion</h3><p>TNF-α, TGF-β, and lower urinary tract symptoms severity can predict the occurrence of ED in BPH, while prostatic volume was not significant.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 280-285"},"PeriodicalIF":2.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388223000929/pdfft?md5=30481fee0e8afc9362894c7d8b3acabd&pid=1-s2.0-S2214388223000929-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45667096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective randomized study to evaluate and compare the post-procedural sexual function in patients undergoing semi-rigid ureterorenoscopy for distal ureteric stones in three different operating room settings 一项前瞻性随机研究,评估和比较三种不同手术方式下输尿管远端结石患者行半刚性输尿管镜手术后的性功能
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-04-01 DOI: 10.1016/j.ajur.2022.08.004
Gajanan S. Bhat , Anuradha Shastry

Objective

To evaluate and compare the effect of semi-rigid ureterorenoscopy on post-procedural sexual function with three different operating room settings.

Methods

In this prospective randomized study, consecutive sexually active patients with normal pre-operative sexual function undergoing uncomplicated semi-rigid ureterorenoscopy for distal ureteric stones were randomized into three groups, with three different operating room settings. Procedure-related anxiety and sexual function were assessed pre-operatively using Amsterdam Preoperative Anxiety and Information Scale and Brief Sexual Function Inventory (in males) and Female Sexual Function Index-6 (in females), respectively. All the participants were stented following the procedure, and the stent was removed after 3 weeks. Post-procedural sexual function and general discomfort were assessed and compared between three groups at 1 week, 3 weeks, and 12 weeks. The effect of surgery-related anxiety, preoperative sexual function, age, and general discomfort (including stent-related discomfort) on post-procedural sexual function were analyzed using multiple regression analysis. A p-value of less than 0.05 was considered statistically significant.

Results

Totally, 327 eligible patients were randomized into three groups. The group of patients who underwent the procedural with a screen separating the operating area from the patient vision, while the patient could watch the endoscopy through a separate monitor, had better post-procedural sexual function compared to those who had total vision of the operating area as well as to those whose eyes were blocked. This difference was statistically significant. This post-procedural reduction in sexual function could not be attributed to in situ stent alone.

Conclusions

Our study showed that semi-rigid ureterorenoscopy can have significant negative effect on sexual function, which can be reduced with proper preoperative counseling and an ideal operating room settings.

方法在这项前瞻性随机研究中,将连续接受无并发症输尿管远端结石半硬性输尿管镜检查的性活跃且术前性功能正常的患者随机分为三组,并采用三种不同的手术室环境。术前分别使用阿姆斯特丹术前焦虑和信息量表、简明性功能量表(男性)和女性性功能指数-6(女性)评估与手术相关的焦虑和性功能。所有参与者在手术后都植入了支架,并在 3 周后移除支架。在 1 周、3 周和 12 周时对三组患者进行术后性功能和全身不适的评估和比较。采用多元回归分析法分析了手术相关焦虑、术前性功能、年龄和全身不适(包括支架相关不适)对术后性功能的影响。结果共有 327 名符合条件的患者被随机分为三组。接受手术时,手术区与患者视线之间有屏幕隔开,而患者可以通过一个单独的显示器观看内窥镜检查的那组患者,其术后性功能要好于手术区视线完全被遮挡的患者,也好于视线被遮挡的患者。这一差异在统计学上具有显著意义。结论:我们的研究表明,半硬性输尿管造影术会对性功能产生明显的负面影响,但通过适当的术前咨询和理想的手术室环境可以减少这种影响。
{"title":"Prospective randomized study to evaluate and compare the post-procedural sexual function in patients undergoing semi-rigid ureterorenoscopy for distal ureteric stones in three different operating room settings","authors":"Gajanan S. Bhat ,&nbsp;Anuradha Shastry","doi":"10.1016/j.ajur.2022.08.004","DOIUrl":"10.1016/j.ajur.2022.08.004","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate and compare the effect of semi-rigid ureterorenoscopy on post-procedural sexual function with three different operating room settings.</p></div><div><h3>Methods</h3><p>In this prospective randomized study, consecutive sexually active patients with normal pre-operative sexual function undergoing uncomplicated semi-rigid ureterorenoscopy for distal ureteric stones were randomized into three groups, with three different operating room settings. Procedure-related anxiety and sexual function were assessed pre-operatively using Amsterdam Preoperative Anxiety and Information Scale and Brief Sexual Function Inventory (in males) and Female Sexual Function Index-6 (in females), respectively. All the participants were stented following the procedure, and the stent was removed after 3 weeks. Post-procedural sexual function and general discomfort were assessed and compared between three groups at 1 week, 3 weeks, and 12 weeks. The effect of surgery-related anxiety, preoperative sexual function, age, and general discomfort (including stent-related discomfort) on post-procedural sexual function were analyzed using multiple regression analysis. A <em>p</em>-value of less than 0.05 was considered statistically significant.</p></div><div><h3>Results</h3><p>Totally, 327 eligible patients were randomized into three groups. The group of patients who underwent the procedural with a screen separating the operating area from the patient vision, while the patient could watch the endoscopy through a separate monitor, had better post-procedural sexual function compared to those who had total vision of the operating area as well as to those whose eyes were blocked. This difference was statistically significant. This post-procedural reduction in sexual function could not be attributed to <em>in situ</em> stent alone.</p></div><div><h3>Conclusions</h3><p>Our study showed that semi-rigid ureterorenoscopy can have significant negative effect on sexual function, which can be reduced with proper preoperative counseling and an ideal operating room settings.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 331-338"},"PeriodicalIF":2.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388222001643/pdfft?md5=b5e7703949e5e928e4cd522106a4e178&pid=1-s2.0-S2214388222001643-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46821795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flexible ureteroscopic treatment of kidney stones: How do the new laser systems change our concepts? 输尿管软镜治疗肾结石:新型激光系统如何改变我们的观念?
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-04-01 DOI: 10.1016/j.ajur.2023.11.001
Simin Yu, Linhu Liu, Ya Li, Liang Zhou, Jixiang Chen, Hong Li, Kunjie Wang

Objective

Flexible ureteroscopy (fURS) has become a widely accepted and effective technique for treating kidney stones. With the development of new laser systems, the fURS approach has evolved significantly. This literature review aims to examine the current state of knowledge on fURS treatment of kidney stones, with a particular focus on the impact of the latest laser technologies on clinical outcomes and patient safety.

Methods

We conducted a search of the PubMed/PMC, Web of Science Core Collection, Scopus, Embase (Ovid), and Cochrane Databases for all randomized controlled trial articles on laser lithotripsy in September 2023 without time restriction.

Results

We found a total of 22 relevant pieces of literature. Holmium laser has been used for intracavitary laser lithotripsy for nearly 30 years and has become the golden standard for the treatment of urinary stones. However, the existing holmium laser cannot completely powder the stone, and the retropulsion of the stone after the laser emission and the thermal damage to the tissue have caused many problems for clinicians. The introduction of thulium fiber laser and Moses technology brings highly efficient dusting lithotripsy effect through laser innovation, limiting pulse energy and broadening pulse frequency.

Conclusion

While the holmium:yttrium-aluminum-garnet laser remains the primary choice for endoscopic laser lithotripsy, recent technological advancements hint at a potential new gold standard. Parameter range, retropulsion effect, laser fiber adaptability, and overall system performance demand comprehensive attention. The ablation efficacy of high-pulse-frequency devices relies on precise targeting, which may pose practical challenges.

目的柔性输尿管镜检查(fURS)已成为治疗肾结石的一种广为接受的有效技术。随着新型激光系统的发展,输尿管软镜技术也有了长足的进步。本文献综述旨在研究 fURS 治疗肾结石的知识现状,尤其关注最新激光技术对临床结果和患者安全的影响。方法我们在 PubMed/PMC、Web of Science Core Collection、Scopus、Embase (Ovid) 和 Cochrane 数据库中搜索了 2023 年 9 月所有关于激光碎石的随机对照试验文章,没有时间限制。钬激光用于腔内激光碎石已有近 30 年的历史,已成为治疗泌尿系结石的黄金标准。然而,现有的钬激光并不能完全粉化结石,激光发射后结石的逆推和对组织的热损伤给临床医生带来了很多问题。铥光纤激光器和摩西技术的引入,通过激光创新、限制脉冲能量和拓宽脉冲频率,带来了高效的除尘碎石效果。 结论尽管钬钇铝石榴石激光器仍是内镜激光碎石术的主要选择,但最近的技术进步暗示着潜在的新黄金标准。参数范围、逆推效应、激光光纤适应性和整个系统的性能都需要全面关注。高脉冲频率设备的消融效果取决于精确定位,这可能会带来实际挑战。
{"title":"Flexible ureteroscopic treatment of kidney stones: How do the new laser systems change our concepts?","authors":"Simin Yu,&nbsp;Linhu Liu,&nbsp;Ya Li,&nbsp;Liang Zhou,&nbsp;Jixiang Chen,&nbsp;Hong Li,&nbsp;Kunjie Wang","doi":"10.1016/j.ajur.2023.11.001","DOIUrl":"10.1016/j.ajur.2023.11.001","url":null,"abstract":"<div><h3>Objective</h3><p>Flexible ureteroscopy (fURS) has become a widely accepted and effective technique for treating kidney stones. With the development of new laser systems, the fURS approach has evolved significantly. This literature review aims to examine the current state of knowledge on fURS treatment of kidney stones, with a particular focus on the impact of the latest laser technologies on clinical outcomes and patient safety.</p></div><div><h3>Methods</h3><p>We conducted a search of the PubMed/PMC, Web of Science Core Collection, Scopus, Embase (Ovid), and Cochrane Databases for all randomized controlled trial articles on laser lithotripsy in September 2023 without time restriction.</p></div><div><h3>Results</h3><p>We found a total of 22 relevant pieces of literature. Holmium laser has been used for intracavitary laser lithotripsy for nearly 30 years and has become the golden standard for the treatment of urinary stones. However, the existing holmium laser cannot completely powder the stone, and the retropulsion of the stone after the laser emission and the thermal damage to the tissue have caused many problems for clinicians. The introduction of thulium fiber laser and Moses technology brings highly efficient dusting lithotripsy effect through laser innovation, limiting pulse energy and broadening pulse frequency.</p></div><div><h3>Conclusion</h3><p>While the holmium:yttrium-aluminum-garnet laser remains the primary choice for endoscopic laser lithotripsy, recent technological advancements hint at a potential new gold standard. Parameter range, retropulsion effect, laser fiber adaptability, and overall system performance demand comprehensive attention. The ablation efficacy of high-pulse-frequency devices relies on precise targeting, which may pose practical challenges.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 156-168"},"PeriodicalIF":2.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388224000195/pdfft?md5=3337cc9215bd57dc0ebb81b935d7ff58&pid=1-s2.0-S2214388224000195-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140468191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-aspect analysis of ureteral access sheath usage in retrograde intrarenal surgery: A RIRSearch group study 肾内逆行手术中输尿管入路鞘使用的多方面分析:RIRS研究组研究
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.ajur.2021.11.004
Oktay Özman , Hacı M. Akgül , Cem Başataç , Önder Çınar , Eyüp B. Sancak , Cenk M. Yazıcı , Bülent Önal , Haluk Akpınar , on behalf of the RIRSearch Study Group

Objective

To evaluate the effect of ureteral access sheath (UAS) use and calibration change on stone-free rate and complications of retrograde intrarenal surgery (RIRS).

Methods

Data from 568 patients undergoing RIRS for kidney or upper ureteral stones were retrospectively included. Firstly, patients were compared after 1:1 propensity score matching, according to UAS usage during RIRS (UAS used [+] 87 and UAS non-used [] 87 patients). Then all UAS+ patients (n=481) were subdivided according to UAS calibration: 9.5–11.5 Fr, 10–12 Fr, 11–13 Fr, and 13–15 Fr. Primary outcomes of the study were the success and complications of RIRS.

Results

Stone-free rate of UAS+ patients (86.2%) was significantly higher than UAS patients (70.1%) after propensity score matching (p=0.01). Stone-free rate increased with higher caliber UAS (9.5–11.5 Fr: 66.7%; 10–12 Fr: 87.0%; 11–13 Fr: 90.6%; 13–15 Fr: 100%; p<0.001). Postoperative complications of UAS+ patients (11.5%) were significantly lower than UAS patients (27.6%) (p=0.01). Complications (8.7%) with 9.5–11.5 Fr UAS was lower than thicker UAS (17.2%) but was not statistically significant (p=0.09). UAS usage was an independent factor predicting stone-free status or peri- and post-operative complications (odds ratio [OR] 3.654, 95% confidence interval [CI] 1.314–10.162; OR 4.443, 95% CI 1.350–14.552; OR 4.107, 95% CI 1.366–12.344, respectively).

Conclusion

Use of UAS in RIRS may increase stone-free rates, which also increase with higher caliber UAS. UAS usage may reduce complications; however, complications seemingly increase with higher UAS calibration.

方法 回顾性纳入568例因肾结石或输尿管上段结石接受逆行肾内手术(RIRS)的患者数据。首先,根据 RIRS 期间使用 UAS 的情况(使用 UAS [+] 87 例患者和未使用 UAS [-] 87 例患者),对患者进行 1:1 倾向评分匹配比较。研究的主要结果是 RIRS 的成功率和并发症。结果倾向得分匹配后,UAS+ 患者的无结石率(86.2%)明显高于 UAS- 患者(70.1%)(P=0.01)。无结石率随 UAS 口径增大而增加(9.5-11.5 Fr:66.7%;10-12 Fr:87.0%; 11-13 Fr:90.6%;13-15 Fr:100%;P<0.001)。UAS+ 患者的术后并发症(11.5%)明显低于 UAS- 患者(27.6%)(P=0.01)。使用 9.5-11.5 Fr UAS 的并发症(8.7%)低于使用较厚 UAS 的并发症(17.2%),但无统计学意义(P=0.09)。使用 UAS 是预测无结石状态或术前术后并发症的独立因素(几率比 [OR] 3.654,95% 置信区间 [CI] 1.314-10.162;OR 4.443,95% 置信区间 [CI] 1.350-14.552;OR 4.107,95% 置信区间 [CI] 1.366-12.344)。使用 UAS 可以减少并发症;但是,并发症似乎会随着 UAS 校准程度的提高而增加。
{"title":"Multi-aspect analysis of ureteral access sheath usage in retrograde intrarenal surgery: A RIRSearch group study","authors":"Oktay Özman ,&nbsp;Hacı M. Akgül ,&nbsp;Cem Başataç ,&nbsp;Önder Çınar ,&nbsp;Eyüp B. Sancak ,&nbsp;Cenk M. Yazıcı ,&nbsp;Bülent Önal ,&nbsp;Haluk Akpınar ,&nbsp;on behalf of the RIRSearch Study Group","doi":"10.1016/j.ajur.2021.11.004","DOIUrl":"10.1016/j.ajur.2021.11.004","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of ureteral access sheath (UAS) use and calibration change on stone-free rate and complications of retrograde intrarenal surgery (RIRS).</p></div><div><h3>Methods</h3><p>Data from 568 patients undergoing RIRS for kidney or upper ureteral stones were retrospectively included. Firstly, patients were compared after 1:1 propensity score matching, according to UAS usage during RIRS (UAS used [<sup>+</sup>] 87 and UAS non-used [<sup>−</sup>] 87 patients). Then all UAS<sup>+</sup> patients (<em>n</em>=481) were subdivided according to UAS calibration: 9.5–11.5 Fr, 10–12 Fr, 11–13 Fr, and 13–15 Fr. Primary outcomes of the study were the success and complications of RIRS.</p></div><div><h3>Results</h3><p>Stone-free rate of UAS<sup>+</sup> patients (86.2%) was significantly higher than UAS<sup>−</sup> patients (70.1%) after propensity score matching (<em>p</em>=0.01). Stone-free rate increased with higher caliber UAS (9.5–11.5 Fr: 66.7%; 10–12 Fr: 87.0%; 11–13 Fr: 90.6%; 13–15 Fr: 100%; <em>p</em>&lt;0.001). Postoperative complications of UAS<sup>+</sup> patients (11.5%) were significantly lower than UAS<sup>−</sup> patients (27.6%) (<em>p</em>=0.01). Complications (8.7%) with 9.5–11.5 Fr UAS was lower than thicker UAS (17.2%) but was not statistically significant (<em>p</em>=0.09). UAS usage was an independent factor predicting stone-free status or peri- and post-operative complications (odds ratio [OR] 3.654, 95% confidence interval [CI] 1.314–10.162; OR 4.443, 95% CI 1.350–14.552; OR 4.107, 95% CI 1.366–12.344, respectively).</p></div><div><h3>Conclusion</h3><p>Use of UAS in RIRS may increase stone-free rates, which also increase with higher caliber UAS. UAS usage may reduce complications; however, complications seemingly increase with higher UAS calibration.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 80-85"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388221001089/pdfft?md5=d212c3da4e21af038a20fc249571c277&pid=1-s2.0-S2214388221001089-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45674243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we predict the incidence of high-grade Clavien-Dindo complications in patients with forgotten encrusted stents undergoing endourologic management? 我们能否预测遗忘包覆支架患者接受泌尿系统管理时高级别Clavien并发症的发生率?
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.ajur.2022.03.018
Praanjal Gupta, Ramanitharan Manikandan, Lalgudi Narayanan Dorairajan, Kodakattil Sreenivasan Sreerag, Sidhartha Kalra, Swapnil Singh Kushwaha

Objective

Ureteral stents are customarily inserted to facilitate urinary drainage, but they come with their own glitches of being forgotten and/or encrusted leading to serious consequences. The present study aimed to report the complications in patients with forgotten and encrusted stents according to the Clavien-Dindo system specific to urological procedures and identify the factors leading to high-grade (Clavien-Dindo Grade 4A or above) complications.

Methods

The hospital records of patients with forgotten encrusted double-J stents over a period of 8 years were reviewed. The parameters recorded included patient demographics, indwelling time, need for percutaneous nephrostomy, hemodialysis, urine culture, blood culture, total blood counts, serum creatinine, radiologic findings, management techniques, number of surgical interventions, modified Clavien-Dindo complications, follow-up, and mortality, if any.

Results

Forty patients were included in the study. The median age was 52 (range 6–85) years. Of the total, 25 (62.5%) patients had a “significant” stent load; 31 (77.5%) had renal failure or acute kidney injury on presentation; 19 (47.5%) patients had sepsis at presentation. Among the patients presented with sepsis, 11 (57.9%) patients demonstrated a positive urine culture; and 7/11 (63.6%) patients exhibited pan-resistant organisms. Twelve out of 40 (30.0%) patients in our series developed high-grade Clavien-Dindo complications. On univariate analysis, sepsis at presentation (p=0.007), stent load (p=0.031), diabetes (p=0.023), positive urine culture (p=0.007), and stent indwelling time of more than 1 year (p=0.031) were found to be significant. On multivariate logistic regression analysis, sepsis at presentation (p=0.017) and positive urine culture (p=0.016) were significant predictors for high-grade complications.

Conclusion

It is prudent to identify specific risk factors, namely sepsis at presentation and positive urine culture to triage and optimize these patients before surgical management.

目的:输尿管支架通常是为了方便排尿而插入的,但也有被遗忘和/或结壳导致严重后果的小问题。本研究旨在根据泌尿外科手术专用的 Clavien-Dindo 系统报告遗忘和结壳支架患者的并发症,并确定导致高级别(Clavien-Dindo 4A 级或以上)并发症的因素。记录的参数包括患者的人口统计学特征、留置时间、经皮肾造瘘术需求、血液透析、尿培养、血培养、总血细胞计数、血清肌酐、放射学检查结果、处理技术、手术干预次数、改良的克拉维恩-丁多并发症、随访和死亡率(如有)。中位年龄为 52 岁(6-85 岁)。其中,25 例(62.5%)患者的支架负荷 "显著";31 例(77.5%)患者在就诊时出现肾衰竭或急性肾损伤;19 例(47.5%)患者在就诊时出现败血症。在出现败血症的患者中,11 名患者(57.9%)尿培养呈阳性;7/11 名患者(63.6%)出现泛耐药菌。在我们的系列研究中,40 名患者中有 12 名(30.0%)出现了高级别的克拉维恩-丁多并发症。单变量分析发现,发病时的败血症(p=0.007)、支架负荷(p=0.031)、糖尿病(p=0.023)、尿培养阳性(p=0.007)和支架留置时间超过 1 年(p=0.031)具有显著性。在多变量逻辑回归分析中,发病时的败血症(p=0.017)和尿培养阳性(p=0.016)是高度并发症的重要预测因素。
{"title":"Can we predict the incidence of high-grade Clavien-Dindo complications in patients with forgotten encrusted stents undergoing endourologic management?","authors":"Praanjal Gupta,&nbsp;Ramanitharan Manikandan,&nbsp;Lalgudi Narayanan Dorairajan,&nbsp;Kodakattil Sreenivasan Sreerag,&nbsp;Sidhartha Kalra,&nbsp;Swapnil Singh Kushwaha","doi":"10.1016/j.ajur.2022.03.018","DOIUrl":"10.1016/j.ajur.2022.03.018","url":null,"abstract":"<div><h3>Objective</h3><p>Ureteral stents are customarily inserted to facilitate urinary drainage, but they come with their own glitches of being forgotten and/or encrusted leading to serious consequences. The present study aimed to report the complications in patients with forgotten and encrusted stents according to the Clavien-Dindo system specific to urological procedures and identify the factors leading to high-grade (Clavien-Dindo Grade 4A or above) complications.</p></div><div><h3>Methods</h3><p>The hospital records of patients with forgotten encrusted double-J stents over a period of 8 years were reviewed. The parameters recorded included patient demographics, indwelling time, need for percutaneous nephrostomy, hemodialysis, urine culture, blood culture, total blood counts, serum creatinine, radiologic findings, management techniques, number of surgical interventions, modified Clavien-Dindo complications, follow-up, and mortality, if any.</p></div><div><h3>Results</h3><p>Forty patients were included in the study. The median age was 52 (range 6–85) years. Of the total, 25 (62.5%) patients had a “significant” stent load; 31 (77.5%) had renal failure or acute kidney injury on presentation; 19 (47.5%) patients had sepsis at presentation. Among the patients presented with sepsis, 11 (57.9%) patients demonstrated a positive urine culture; and 7/11 (63.6%) patients exhibited pan-resistant organisms. Twelve out of 40 (30.0%) patients in our series developed high-grade Clavien-Dindo complications. On univariate analysis, sepsis at presentation (<em>p</em>=0.007), stent load (<em>p</em>=0.031), diabetes (<em>p</em>=0.023), positive urine culture (<em>p</em>=0.007), and stent indwelling time of more than 1 year (<em>p</em>=0.031) were found to be significant. On multivariate logistic regression analysis, sepsis at presentation (<em>p</em>=0.017) and positive urine culture (<em>p</em>=0.016) were significant predictors for high-grade complications.</p></div><div><h3>Conclusion</h3><p>It is prudent to identify specific risk factors, namely sepsis at presentation and positive urine culture to triage and optimize these patients before surgical management.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 99-104"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388223000036/pdfft?md5=889e86318f6eccee24a0c3379fdb87be&pid=1-s2.0-S2214388223000036-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43947651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary unifocal penile follicular center non-Hodgkin lymphoma: Report of a rare case and review of the literature 原发性单灶性阴茎滤泡中心非霍奇金淋巴瘤:一例罕见病例报告及文献复习
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.ajur.2023.03.003
Nikolaos Kostakopoulos, Christos Masaoutis, Vasileios Argyropoulos, Varvara Pantelaion, Panagiotis Theodoropoulos, Panagiotis Kouroupakis, Athanasios Kostakopoulos
{"title":"Primary unifocal penile follicular center non-Hodgkin lymphoma: Report of a rare case and review of the literature","authors":"Nikolaos Kostakopoulos,&nbsp;Christos Masaoutis,&nbsp;Vasileios Argyropoulos,&nbsp;Varvara Pantelaion,&nbsp;Panagiotis Theodoropoulos,&nbsp;Panagiotis Kouroupakis,&nbsp;Athanasios Kostakopoulos","doi":"10.1016/j.ajur.2023.03.003","DOIUrl":"10.1016/j.ajur.2023.03.003","url":null,"abstract":"","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 134-136"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388223000395/pdfft?md5=bf9ebdeb9f271e089ab6142b3f01b4fe&pid=1-s2.0-S2214388223000395-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44126864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial 他达拉非改善 COVID-19 引起的男性勃起功能障碍的疗效:随机安慰剂对照试验
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.ajur.2022.05.006
Iman Shamohammadi , Seyedmohammad Kazemeyni , Mohammadali Sadighi , Tara Hasanzadeh , Alireza Dizavi

Objective

According to the high prevalence of COVID-19 and the subsequent risk of men's sexual health, we decided to investigate the efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19.

Methods

In this study, 70 outpatients who were recovered from COVID-19 without acute respiratory distress syndrome with negative polymerase chain reaction test and a complaint of erectile dysfunction were divided into two groups: 35 patients who received tadalafil 5 mg daily and 35 who received placebo. For each patient, basic assessment of sexual function was performed using the 5-item version of the International Index of Erectile Function (IIEF-5) questionnaire. Then, treatment was started from 2 months after complete recovery of COVID-19 with negative polymerase chain reaction test for 3 months. At the end of the treatments, the patients were re-evaluated for sexual function using the complete version of IIEF questionnaire. Finally, the results before and after treatment in the intervention group were compared with those of the control group.

Results

Treatment with both tadalafil and placebo improved the patients' sexual function criteria compared to the baseline. However, this improvement was significantly higher in the intervention group with tadalafil than the control group with placebo (p<0.05).

Conclusion

Daily administration of tadalafil 5 mg seems to be effective and safe for improvement of erectile dysfunction caused by COVID-19.

方法 在这项研究中,我们将70名从COVID-19中康复且无急性呼吸窘迫综合征、聚合酶链反应试验阴性、主诉勃起功能障碍的门诊患者分为两组:35名患者每天服用5毫克他达拉非,35名患者服用安慰剂。每名患者均使用 5 项版国际勃起功能指数(IIEF-5)问卷进行性功能基本评估。然后,在 COVID-19 完全恢复且聚合酶链反应检测呈阴性后 2 个月开始治疗,为期 3 个月。治疗结束后,使用完整版 IIEF 问卷对患者的性功能进行重新评估。结果与基线相比,他达拉非和安慰剂治疗均改善了患者的性功能标准。结论每天服用 5 毫克他达拉非似乎对改善 COVID-19 引起的勃起功能障碍有效且安全。
{"title":"Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial","authors":"Iman Shamohammadi ,&nbsp;Seyedmohammad Kazemeyni ,&nbsp;Mohammadali Sadighi ,&nbsp;Tara Hasanzadeh ,&nbsp;Alireza Dizavi","doi":"10.1016/j.ajur.2022.05.006","DOIUrl":"10.1016/j.ajur.2022.05.006","url":null,"abstract":"<div><h3>Objective</h3><p>According to the high prevalence of COVID-19 and the subsequent risk of men's sexual health, we decided to investigate the efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19.</p></div><div><h3>Methods</h3><p>In this study, 70 outpatients who were recovered from COVID-19 without acute respiratory distress syndrome with negative polymerase chain reaction test and a complaint of erectile dysfunction were divided into two groups: 35 patients who received tadalafil 5 mg daily and 35 who received placebo. For each patient, basic assessment of sexual function was performed using the 5-item version of the International Index of Erectile Function (IIEF-5) questionnaire. Then, treatment was started from 2 months after complete recovery of COVID-19 with negative polymerase chain reaction test for 3 months. At the end of the treatments, the patients were re-evaluated for sexual function using the complete version of IIEF questionnaire. Finally, the results before and after treatment in the intervention group were compared with those of the control group.</p></div><div><h3>Results</h3><p>Treatment with both tadalafil and placebo improved the patients' sexual function criteria compared to the baseline. However, this improvement was significantly higher in the intervention group with tadalafil than the control group with placebo (<em>p</em>&lt;0.05).</p></div><div><h3>Conclusion</h3><p>Daily administration of tadalafil 5 mg seems to be effective and safe for improvement of erectile dysfunction caused by COVID-19.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 128-133"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40715457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates 前列腺癌症患者经尿道前列腺手术并发症和死亡率的人群比较分析
IF 2.6 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.ajur.2022.05.008
Michele Marchioni , Giulia Primiceri , Alessandro Veccia , Marta Di Nicola , Umberto Carbonara , Fabio Crocerossa , Ugo Falagario , Ambra Rizzoli , Riccardo Autorino , Luigi Schips

Objective

Prostate cancer (PCa) patients might experience lower urinary tract symptoms as those diagnosed with benign prostatic hyperplasia (BPH). Some of them might be treated for their lower urinary tract symptoms instead of PCa. We aimed to test the effect of PCa versus BPH on surgical outcomes after transurethral prostate surgery, namely complication and mortality rates.

Methods

Within the American College of Surgeons National Surgical Quality Improvement Program database (2011–2016), we identified patients who underwent transurethral resection of the prostate, photoselective vaporization, or laser enucleation. Patients were stratified according to postoperative diagnosis (PCa vs. BPH). Univariable and multivariable logistic regression models evaluated the predictors of perioperative morbidity and mortality. A formal test of interaction between diagnosis and surgical technique used was performed.

Results

Overall, 34 542 patients were included. Of all, 2008 (5.8%) had a diagnosis of PCa. The multivariable logistic regression model failed to show statistically significant higher rates of postoperative complications in PCa patients (odds ratio: 0.9, 95% confidence interval: 0.7–1.1; p=0.252). Moreover, similar rates of perioperative mortality (p=0.255), major acute cardiovascular events (p=0.581), transfusions (p=0.933), and length of stay of more than or equal to 30 days (p=0.174) were found. Additionally, all tests failed to show an interaction between post-operative diagnosis and surgical technique used.

Conclusion

Patients diagnosed with PCa do not experience higher perioperative morbidity or mortality after transurethral prostate surgery when compared to their BPH counterparts. Moreover, the diagnosis seems to not influence surgical technique outcomes.

目的前列腺癌(PCa)患者可能会像良性前列腺增生症(BPH)患者一样出现下尿路症状。他们中的一些人可能会因为下尿路症状而接受治疗,而不是PCa。我们旨在检验 PCa 与 BPH 对经尿道前列腺手术后的手术结果(即并发症和死亡率)的影响。方法在美国外科学院国家外科质量改进计划数据库(2011-2016 年)中,我们确定了接受经尿道前列腺切除术、光选择性汽化术或激光去核术的患者。根据术后诊断(PCa 与良性前列腺增生)对患者进行分层。单变量和多变量逻辑回归模型评估了围手术期发病率和死亡率的预测因素。对诊断和所用手术技术之间的相互作用进行了正式检验。其中,2008 例(5.8%)确诊为 PCa。多变量逻辑回归模型未能显示 PCa 患者的术后并发症发生率有显著的统计学意义(几率比:0.9,95% 置信区间:0.7-1.1;P=0.252)。此外,围手术期死亡率(p=0.255)、主要急性心血管事件(p=0.581)、输血(p=0.933)和住院时间超过或等于 30 天(p=0.174)的发生率也相似。结论与良性前列腺增生症患者相比,确诊为 PCa 的患者在经尿道前列腺手术后的围手术期发病率或死亡率并不高。此外,诊断似乎也不会影响手术技术的结果。
{"title":"Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates","authors":"Michele Marchioni ,&nbsp;Giulia Primiceri ,&nbsp;Alessandro Veccia ,&nbsp;Marta Di Nicola ,&nbsp;Umberto Carbonara ,&nbsp;Fabio Crocerossa ,&nbsp;Ugo Falagario ,&nbsp;Ambra Rizzoli ,&nbsp;Riccardo Autorino ,&nbsp;Luigi Schips","doi":"10.1016/j.ajur.2022.05.008","DOIUrl":"10.1016/j.ajur.2022.05.008","url":null,"abstract":"<div><h3>Objective</h3><p>Prostate cancer (PCa) patients might experience lower urinary tract symptoms as those diagnosed with benign prostatic hyperplasia (BPH). Some of them might be treated for their lower urinary tract symptoms instead of PCa. We aimed to test the effect of PCa versus BPH on surgical outcomes after transurethral prostate surgery, namely complication and mortality rates.</p></div><div><h3>Methods</h3><p>Within the American College of Surgeons National Surgical Quality Improvement Program database (2011–2016), we identified patients who underwent transurethral resection of the prostate, photoselective vaporization, or laser enucleation. Patients were stratified according to postoperative diagnosis (PCa <em>vs.</em> BPH). Univariable and multivariable logistic regression models evaluated the predictors of perioperative morbidity and mortality. A formal test of interaction between diagnosis and surgical technique used was performed.</p></div><div><h3>Results</h3><p>Overall, 34 542 patients were included. Of all, 2008 (5.8%) had a diagnosis of PCa. The multivariable logistic regression model failed to show statistically significant higher rates of postoperative complications in PCa patients (odds ratio: 0.9, 95% confidence interval: 0.7–1.1; <em>p</em>=0.252). Moreover, similar rates of perioperative mortality (<em>p</em>=0.255), major acute cardiovascular events (<em>p</em>=0.581), transfusions (<em>p</em>=0.933), and length of stay of more than or equal to 30 days (<em>p</em>=0.174) were found. Additionally, all tests failed to show an interaction between post-operative diagnosis and surgical technique used.</p></div><div><h3>Conclusion</h3><p>Patients diagnosed with PCa do not experience higher perioperative morbidity or mortality after transurethral prostate surgery when compared to their BPH counterparts. Moreover, the diagnosis seems to not influence surgical technique outcomes.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 48-54"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388222000947/pdfft?md5=1ea81e3623c2c8615b73f4b32c7c6711&pid=1-s2.0-S2214388222000947-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44673322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Journal of Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1